Sunday, November 17, 2024
HomeIndustries

Industries

Sandoz submits Marketing Authorization Application for proposed biosimilar trastuzumab to EMA

Sandoz, a global leader in generic and biosimilar medicines, announced that it has submitted a Marketing Authorization Application for a proposed biosimilar trastuzumab (150...

RAFA Enters into Negotiations with JINR for Ultra-Cutting Edge Nuclear Research

Rafarma Pharmaceuticals, Inc. OTC:(RAFA) is currently negotiating with the Joint Institute for Nuclear Research (JINR), an international intergovernmental scientific organization established by eleven founding...

MedMira Announces VYRA CoV2Flu and Additional Regulatory Opportunities

MedMira Inc. announces the expansion of its VYRA product line by launching its VYRA CoV2Flu Rapid Antigen Rapid Test (VYRA™ CoV2Flu). Based on MedMira’s...

Valneva Announces Positive Lot-to-Lot Consistency Trial Results for its Single-Shot Chikungunya Vaccine Candidate

Valneva SE ,a specialty vaccine company, announced positive topline results from the lot-to-lot Phase 3 trial of its single-shot chikungunya vaccine candidate, VLA1553. The...

IMCD Australia & New Zealand strengthen its home care and water treatment portfolios with the acquisition of RPL Trading

IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, announces that IMCD Australia & New Zealand have signed an agreement...
0FansLike
0FollowersFollow
spot_img

Hot Topics